Raben David

CIK 00020346791 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002034679

Recent Transactions

27 trades

Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-04-27$22.88/sh−5,500→ 55,286 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-04-27−5,500→ 41,913 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-04-27$3.79/sh+5,500→ 60,786 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-25$3.79/sh+5,500→ 60,786 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-25$18.95/sh−5,500→ 55,286 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-25−5,500→ 47,413 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$3.79/sh+16,300→ 71,586 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$18.52/sh−16,300→ 55,286 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-04−16,300→ 52,913 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$18.45/sh−200→ 55,286 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-03−200→ 69,213 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$3.79/sh+200→ 55,486 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-02+100,000→ 100,000 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-26$3.79/sh+19,789→ 55,286 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-12-26−19,789→ 98,987 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-25$3.79/sh+906→ 36,403 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-25$18.84/sh−906→ 35,497 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-25−4,594→ 118,776 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-25−906→ 69,413 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-25$18.84/sh−4,594→ 35,497 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-25$3.79/sh+4,594→ 40,091 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$18.45/sh−5,500→ 35,497 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-24−5,500→ 123,370 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$3.79/sh+5,500→ 40,997 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-09$3.79/sh+22,000→ 57,497 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-09−22,000→ 128,870 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-09$18.45/sh−22,000→ 35,497 total

Companies

Bicara Therapeutics Inc.
Chief Medical Officer
$BCAX

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov